Figure 4.
Figure 4. The half-life of TM mRNA in HUVECs treated with DRB, ox-LDL, or ox-PAPC. HUVECs were treated with 65 mM DRB alone (DRB), DRB plus 200 μg protein/mL ox-LDL (DRB + ox-LDL), ox-LDL alone (ox-LDL), DRB plus 50 μg/mL ox-PAPC (DRB + ox-PAPC), or ox-PAPC alone (ox-PAPC) for various times. Total RNA was isolated from the cells for RT-PCR analysis as described in “Materials and methods” (A,C). The autoradiogram was analyzed by densitometry and the data are expressed as the percentage of control after normalization to β-actin mRNA levels (B,D). Each symbol (▪, •, and ▴) represents 3 different experiments. The half-life (t 1/2) for each condition was calculated by linear regression analysis from semilog plots of the mRNA remaining versus incubation times and is reported as the mean.

The half-life of TM mRNA in HUVECs treated with DRB, ox-LDL, or ox-PAPC. HUVECs were treated with 65 mM DRB alone (DRB), DRB plus 200 μg protein/mL ox-LDL (DRB + ox-LDL), ox-LDL alone (ox-LDL), DRB plus 50 μg/mL ox-PAPC (DRB + ox-PAPC), or ox-PAPC alone (ox-PAPC) for various times. Total RNA was isolated from the cells for RT-PCR analysis as described in “Materials and methods” (A,C). The autoradiogram was analyzed by densitometry and the data are expressed as the percentage of control after normalization to β-actin mRNA levels (B,D). Each symbol (▪, •, and ▴) represents 3 different experiments. The half-life (t 1/2) for each condition was calculated by linear regression analysis from semilog plots of the mRNA remaining versus incubation times and is reported as the mean.

Close Modal

or Create an Account

Close Modal
Close Modal